SCHEMBL18629040

SCHEMBL18629040

CC(C)CONC1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.40
HTT P42858 2/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SHBG P04278 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GAA P10253 2/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062101 0.76 ALDH1A1 (0.39) EPHX1ALDH1A1HSD17B10KDM4ESHBG
SCHEMBL28088231 0.75 KDM4E (0.44) EPHX1HTTALDH1A1HSD17B10KDM4E
SCHEMBL5504169 0.73 NPSR1 (0.42) EPHX1HTTALDH1A1HSD17B10KDM4E
SCHEMBL31035976 0.73 CYP1A2 (0.41) EPHX1ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL16135444 0.73 CYP1A2 (0.41) EPHX1ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL28377784 0.71 ALDH1A1 (0.39) EPHX1ALDH1A1HSD17B10KDM4ECYP3A4
SCHEMBL11337017 0.71 ALDH1A1 (0.39) EPHX1HTTALDH1A1HSD17B10KDM4E
Hydrochloric Acid SCHEMBL4745599 0.71 CYP1A2 (0.40) EPHX1ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL27425116 0.71 EPHX2 (0.42) EPHX1HTTALDH1A1HSD17B10KDM4E
SCHEMBL13676857 0.70 SHBG (0.41) EPHX1KDM4ESHBGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 EP disclosed